Autopsy report · NCT03105479
Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD)
Cause of deathFunding or business
“Study suspended in October 2017 and terminated April 17, 2018 after decision to discontinue the study drug development”
Life of this trial
- Ran for about 1 year before it stopped.
- 1 participant enrolled.
- Results were posted on the registry 1 year after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2, Phase 3
- Sponsor
- Actelion
- Sponsor type
- Industry
- Conditions
- Clostridium Difficile Infection
- Interventions
- Cadazolid; Vancomycin capsule; Vancomycin solution
- Participants
- 1
- Sites
- 20
- Countries
- Belgium, Canada, Czechia, Hungary, Italy, Poland, Romania, Spain, United States
Trials that died the same way
- Panobinostat/Velcade in Multiple Myeloma
“This study was terminated because the drug company stopped making the study drug” - SCS Research Study
“Business temporarily suspended study January 2023 with intent to include additional cohorts in future. For business reasons, study terminated April 2024.” - Emory Latino Diabetes Education Program
“Enrollment and study activities were suspended in March 2020 due to the COVID-19 pandemic and re-opening the study was delayed pending additional funding. The study was ultimately terminated in January of 2026 due to lack of funding.” - Phase II Study of Aldesleukin (IL-2) Following the Administration of Zanolimumab (Anti-CD4mAb) in Metastatic Melanoma and Metastatic Renal Cancer
“The study was terminated because we were not able to obtain the study drug.” - Inflammation-Induced CNS Glutamate Changes in Depression
“The study was suspended in March 2020 due to the COVID-19 pandemic and ultimately was terminated as it is not safe to test a potent anti-inflammatory drug with ongoing surges of COVID-19.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.